Braskem (BAK) Research & Development (2009 - 2025)

Braskem (BAK) has reported Research & Development for 16 consecutive years, with -$21.5 million the latest figure, recorded in Q1 2025.

• Quarterly Research & Development changed N/A year-over-year to -$21.5 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$286.4 million (changed N/A YoY) and the FY2025 annual result came in at $85.3 million, up 7.1% from the prior year.
• Research & Development climbed to -$21.5 million in Q1 2025 per BAK's latest filing, from -$77.4 million in the prior quarter.
• Over the last five years, Research & Development for BAK reached as high as $88.7 million in Q4 2021 and fell as low as -$101.9 million in Q4 2022.
• A 4-year average of -$36.3 million and a median of -$49.4 million in 2023 frame the typical range for Research & Development.
• The largest YoY upside for Research & Development was 24.07% in 2023 against a maximum downside of 330.67% in 2023.
• Year by year, Research & Development stood at $88.7 million in 2021, then plunged by 214.81% to -$101.9 million in 2022, then increased by 24.07% to -$77.4 million in 2023, then surged by 72.21% to -$21.5 million in 2025.
• According to Business Quant data, Research & Development over the past three periods registered -$21.5 million, -$77.4 million, and -$85.7 million for Q1 2025, Q4 2023, and Q3 2023 respectively.